HopeStage
Back to all studies
CompletedNCT05416229

Psilocybin-assisted therapy to reduce alcohol use

About this title

Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder

Read the official source — NCT05416229
Medication studyAges 20–70DenmarkAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 20 years to 70 years.

Listed locations
FrederiksbergSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 1, 2023
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
Anders Fink-Jensen, MD, DMSci
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Denmark
Age range
From 20 Years to 70 Years
Official registry ID
NCT05416229
Official title
Show the full official title

The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Frederiksberg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Anders Fink-Jensen, MD, DMSci.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin and Maltodextrin.

Who was this study for?

Listed age limits: 20 years to 70 years.

Want to explore more studies?

Explore studies